Latham & Watkins Advises SoftBank Vision Fund 2 in Big Health’s US$75 Million Series C

Firm represents the lead investor in the digital therapeutics company’s latest funding round.

January 19, 2022

Big Health, a digital therapeutics company dedicated to helping millions get back to good mental health, has announced that it raised US$75 million in a Series C funding round, led by new investor SoftBank Vision Fund 2, with participation from ArrowMark Partners and existing investors Octopus Ventures, Gilde Healthcare, Kaiser Permanente Ventures (KPV), and Morningside Ventures. 

Latham & Watkins LLP represents SoftBank Vision Fund 2 with a corporate deal team led by Bay Area partners Saad Khanani and Ben Potter, with Bay Area associate Chris Pham, Century City associate Kojo Hayward, and London associates Daria Les and Hadi Najem. Advice was also provided on intellectual property matters by Bay Area counsel Arielle Singh.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.